Back
Live Ventures 10K Form
Sell
34
LIVE
Live Ventures
Last Price:
24.78
Seasonality Move:
8.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-08-10 | 10Q | LIVE/Live Ventures Quarterly |
2023-05-11 | 10Q | LIVE/Live Ventures Quarterly |
2023-02-09 | 10Q | LIVE/Live Ventures Quarterly |
2022-08-11 | 10Q | LIVE/Live Ventures Quarterly |
2022-05-11 | 10Q | LIVE/Live Ventures Quarterly |
2022-02-10 | 10Q | LIVE/Live Ventures Quarterly |
Receive LIVE News And Ratings
See the #1 stock for the next 7 days that we like better than LIVE
LIVE Financial Statistics
Sales & Book Value
Annual Sales: | $355.17M |
---|---|
Cash Flow: | $-7.46M |
Price / Cash Flow: | 22.43 |
Annual Sales: | $30.45 |
Price / Book: | 0.81 |
Profitability
EPS (TTM): | -2.39000 |
---|---|
Net Income (TTM): | $-7.47M |
Gross Margin: | $115.57M |
Return on Equity: | -7.43% |
Return on Assets: | -1.85% |
Live Ventures Earnings Forecast
Key Live Ventures Financial Ratios
- The Gross Profit Margin over the past 25 years for LIVE is 32.54%.
- The Selling, General & Administrative Expenses for LIVE have been equal to 28.19% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -12,491.18% of Operating Income.
- The Net Earning history of LIVE is -0.03% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 12 years.
Live Ventures Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Household Durables |
Sector: | Consumer Discretionary |
Current Symbol: | LIVE |
CUSIP: | 538142 |
Website: | liveventures.com |
Debt
Debt-to-Equity Ratio: | 1.65 |
---|---|
Current Ratio: | 1.74 |
Quick Ratio: | 0.47 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
LIVE Technical Analysis vs Fundamental Analysis
Sell
34
Live Ventures (LIVE)
is a Sell
Is Live Ventures a Buy or a Sell?
-
Live Ventures stock is rated a Sell
The current Live Ventures [LIVE] share price is $24.56. The Score for LIVE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.